BioCentury
ARTICLE | Company News

Invenra, Oxford BioTherapeutics deal

August 3, 2015 7:00 AM UTC

Invenra and Oxford partnered to identify and characterize a panel of human mAbs against an undisclosed cancer target that Oxford identified using its OGAP discovery platform. Invenra will deliver the ...